July 6, 2020 | Culture Blog
In this feature, Luke Wiggins, who works in the New York office, shares what a week in the life of an Analyst at CBPartners looks like.
April 29, 2020 | Blog
Cumulative costs from patient enrollment scenarios due to COVID-19 will likely generate a significant financial drain on biopharma R&D expenditures. CBPartners' blog post investigates this impact and explores mitigation strategies.
April 14, 2020 | Blog
Disruption in healthcare systems across Europe is rife due to the COVID-19 pandemic, with increasingly strained budgets, and shifting healthcare priorities.